Kenvue Inc. (NYSE:KVUE – Get Free Report) announced a quarterly dividend on Thursday, September 10th. Stockholders of record on Monday, September 21st will be paid a dividend of 0.21 per share on Friday, October 2nd. This represents a c) annualized dividend and a dividend yield of 4.7%. The ex-dividend date of this dividend is Monday, September 21st.
Kenvue has a dividend payout ratio of 68.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Kenvue to earn $1.23 per share next year, which means the company should continue to be able to cover its $0.84 annual dividend with an expected future payout ratio of 68.3%.
Kenvue Stock Up 0.1%
KVUE opened at $17.77 on Friday. The firm has a market cap of $34.14 billion, a price-to-earnings ratio of 20.43, a PEG ratio of 1.58 and a beta of 0.46. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01. The firm’s 50-day simple moving average is $19.09 and its 200-day simple moving average is $18.24. Kenvue has a twelve month low of $14.02 and a twelve month high of $20.13.
About Kenvue
Kenvue Inc is a global consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health products, and baby and family care.
The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; Listerine in oral care; and Johnson’s and Band-Aid in baby care and essential health.
See Also
- Five stocks we like better than Kenvue
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.
